Articles tagged: Esperion

Esperion Therapeutics seeking $70 million in IPO filing

Comments
Posted: May 16, 2013

Esperion Therapeutics President and CEO Tim Mayleben and Chief Science Officer Roger Newton are taking the company public for the second time. Read more »

Crain's Detroit: Former Aastrom CEO returns to Esperion Theraputics in Plymouth Township

Comments
Posted: Jan 04, 2013

The leadership team of one of the most successful pharmaceutical startups in Michigan history is reuniting, according to a report in Crain’s Detroit Business. Read more »